Efficacy of Anti-VEGF Drugs Based Combination Therapies in Recurrent Glioblastoma: Systematic Review and Meta-Analysis.

Solipuram, Vinod; Soltani, Ramin; Venkatesulu, B P; Annam, Saketh; Alavian, Firoozeh; Ghasemi, Sorayya

Solipuram, Vinod; Soltani, Ramin; Venkatesulu, B P; Annam, Saketh; Alavian, Firoozeh; Ghasemi, Sorayya.

Afiliación

Solipuram V; Department of Medicine, Saint Agnes Hospital, Baltimore, MD, USA.
Soltani R; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Venkatesulu BP; Department of Radiation Oncology, Loyola University Stritch School of medicine, Chicago, IL, USA.
Annam S; Edward Hines VA Hospital, Chicago, IL, USA.
Alavian F; Osmania Medical College, Hyderabad, Telangana, India.
Ghasemi S; Department of Biology, School of Basic Sciences, Farhangian University, Tehran, Iran.

Curr Rev Clin Exp Pharmacol ; 2022 May 17.

Article en En | MEDLINE | ID: mdl-35585804

Palabras clave

Anti-angiogenic therapy; Bevacizumab; GBM; Survival outcomes; Vascular endothelial growth factors; rGBM

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: Curr Rev Clin Exp Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google